维普中文期刊产品整合服务
16篇 您的检索式:作者名="JAVLE MM"
    题名 作者 年代 出处 被引量
1Celecoxib and mucosal protection:translation from an anmial model to a phase I clinical trial of celecoxib,irinotecan,and 5-fluorouracil显示文摘Javle MM Cao S Durrani FA 2007Clin Cancer Res2007,13,3:1
2Regular aspirin use and esophageal cancer risk显示文摘Jayaprakash V Menezes RJ Javle MM 2006Int J Cancer2006,119,1:1
3Inhibition of the mammalian target of rapamycin (roTOR) in advanced pancreatic cancer: results of two phase II studies显示文摘Javle MM Shroff RT Xiong H 2010BMC Cancer2010,10,:1
4Inhibition of the mammalian target of rapamycin (roTOR) in advanced pan- creatic cancer: results of two phase Ⅱ studies 显示文摘Javle MM Shroff RT Xiong H 2010BMC Cancer2010,10,:1
5Randomized phase Ⅱ study of gemcitabine (G) plus anti-IGF-1R antibody MK-0646, G plus erlotinib (E) plus MK-0646 and G plus E for advanced pancreatic cancer显示文摘JAVLE MM VARADHACHARY GR FOGELMAN DR 2011J Clin Oncol2011,,:1
6Comprehensive analysis of potential predictive biomarkers for insulin-like growth factor type-1 receptor (IGF-1 R) targeted therapy in pancreatic cancer 显示文摘SHROFF RT JAVLE MM LI D 2011J Clin Oncol2011,,:1
7Neoadjuvant therapy for gastric cancer显示文摘Chadha MK Kuvshinoff BW Javle MM 2005Oncology ( Williston Park)2005,19,9:1
8Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies显示文摘Javle MM Shroff RT Xiong H 2010BMC Cancer2010,,10:1
9Critical appraisal of the roleof sorafenib in thi- management of hepalocellular carcinoma显示文摘Pan JJ Javle M Thinn MM et aJ 2010Hepat Med2010,2,:1
10Epithelial- mesenchymal transition ( EMT ) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer显示文摘JAVLE MM GIBBS JF IWATA KK 2007Ann Surg Oncol2007,14,12:1
11Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer显示文摘Javle MM Gibbs JF Iwata KK 2007Ann Surg Oncol2007,14,12:1
12Neoadjuvant therapy for gastric cancer显示文摘Ch&dha MK Kuvshinoff BW Javle MM 2005Oncology(Williston Park)2005,19,9:1
13Phase I/II study of MK-0646, the humanized monoclonal IGF-1R antibody in combination with gemeitahine or gemeitabine plus erlotinih (E) for advanced pancreatic cancer显示文摘JAVLE MM SHROFF RT BHOSALE B 2010J Clin Oncol2010,28,15:1
14Epithelialmesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer显示文摘Javle MM Gibbs JF Iwata KK 2007Ann Surg Oncol2007,14,12:1
15Neoadjuvant therapy for gastric cancer显示文摘Chadha MK Kuvshinoff BW Javle MM 2005On cology (Williston Park)2005,19,9:1
16Neoadjuvant therapy for gastric cancer显示文摘Chadha MK Kuvshinoff BW Javle MM 2005Ontology (Williston Park)2005,19,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费